C&R Research Past Earnings Performance
Past criteria checks 4/6
C&R Research has been growing earnings at an average annual rate of 64.3%, while the Life Sciences industry saw earnings growing at 22.5% annually. Revenues have been growing at an average rate of 14.5% per year. C&R Research's return on equity is 11.3%, and it has net margins of 8.5%.
Key information
64.3%
Earnings growth rate
129.2%
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | 14.5% |
| Return on equity | 11.3% |
| Net Margin | 8.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How C&R Research makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 56,853 | 4,813 | 48,776 | 0 |
| 31 Dec 23 | 55,102 | 5,549 | 46,308 | 0 |
| 30 Sep 23 | 51,562 | 4,030 | 44,347 | 0 |
| 30 Jun 23 | 50,615 | 4,365 | 43,286 | 0 |
| 31 Mar 23 | 49,674 | 3,780 | 43,138 | 0 |
| 31 Dec 22 | 48,473 | 4,021 | 41,806 | 0 |
| 30 Sep 22 | 46,857 | -2,163 | 40,479 | 0 |
| 30 Jun 22 | 45,532 | -2,614 | 39,726 | 0 |
| 31 Mar 22 | 44,986 | -3,517 | 37,620 | 0 |
| 31 Dec 21 | 43,171 | -3,301 | 35,742 | 0 |
| 31 Dec 19 | 27,203 | -1,682 | 26,302 | 0 |
Quality Earnings: A359090 has high quality earnings.
Growing Profit Margin: A359090's current net profit margins (8.5%) are higher than last year (7.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A359090's earnings have grown significantly by 64.3% per year over the past 5 years.
Accelerating Growth: A359090's earnings growth over the past year (27.3%) is below its 5-year average (64.3% per year).
Earnings vs Industry: A359090 earnings growth over the past year (27.3%) exceeded the Life Sciences industry 12.9%.
Return on Equity
High ROE: A359090's Return on Equity (11.3%) is considered low.